• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸可乐定两种新口服液体制剂用于儿科患者的理化和微生物稳定性。

Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients.

机构信息

a Unidad de Gestión Clínica de Farmacia, Hospital Universitario Virgen Macarena , Sevilla , Spain.

b Unidad de Gestión Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena , Sevilla , Spain.

出版信息

Pharm Dev Technol. 2019 Apr;24(4):465-478. doi: 10.1080/10837450.2018.1514520. Epub 2018 Nov 19.

DOI:10.1080/10837450.2018.1514520
PMID:30124097
Abstract

Pediatric patients present changing physiological features. Because of the lack of land suitable for commercial management, pediatric specialties very often need to prepare extemporaneous formulations to improve the dosage and administration of drugs for children. Oral liquid formulations are the most suitable for pediatric patients. Clonidine is widely used in the pediatric population for opioid withdrawal, hypertensive crisis, attention deficit disorders and hyperactivity syndrome, and as an analgesic in neuropathic cancer pain. The objective was to study the physicochemical and microbiological stability and determine the shelf life of an oral solution containing 20 µg/mL clonidine hydrochloride in different storage conditions (5 ± 3 °C, 25 ± 3 °C, and 40 ± 2 °C). Using raw material with excipients safe for all pediatric age groups, two oral liquid formulations of clonidine hydrochloride were designed (with and without preservatives). Solutions stored at 5 ± 3 °C (with and without preservatives) were physically and microbiologically stable for at least 90 days in closed containers and for 42 days after opening. Two oral solutions of clonidine hydrochloride 20 µg/mL were developed for pediatric use from raw materials that are readily available and easy to process, containing safe excipients that are stable over a long period of time.

摘要

儿科患者呈现出不断变化的生理特征。由于缺乏适合商业管理的土地,儿科专业通常需要准备临时制剂,以改善儿童用药的剂量和给药方式。口服液体制剂最适合儿科患者。可乐定在儿科人群中广泛用于阿片类药物戒断、高血压危象、注意缺陷多动障碍和多动综合征,以及作为神经源性癌痛的镇痛药。目的是研究含有 20μg/ml 盐酸可乐定的口服溶液在不同储存条件(5±3°C、25±3°C 和 40±2°C)下的物理化学和微生物稳定性,并确定其保质期。使用适用于所有儿科年龄组的原料和辅料,设计了两种盐酸可乐定的口服液体制剂(含防腐剂和不含防腐剂)。在 5±3°C(含和不含防腐剂)下储存的溶液在密闭容器中至少稳定 90 天,开封后至少稳定 42 天。从易于获得和易于处理的原料中开发了两种 20μg/ml 盐酸可乐定的口服溶液,适用于儿科使用,含有安全的辅料,在长时间内保持稳定。

相似文献

1
Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients.盐酸可乐定两种新口服液体制剂用于儿科患者的理化和微生物稳定性。
Pharm Dev Technol. 2019 Apr;24(4):465-478. doi: 10.1080/10837450.2018.1514520. Epub 2018 Nov 19.
2
Stability study of a clonidine oral solution in a novel vehicle designed for pediatric patients.一种用于儿科患者的新型载体中环丙胺嗪口服液的稳定性研究。
Pharm Dev Technol. 2018 Dec;23(10):1067-1076. doi: 10.1080/10837450.2017.1389955. Epub 2017 Oct 24.
3
Physicochemical and Microbiological Stability of Compounded Clonidine Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt®.PCCA 基质混悬剂中盐酸可乐定口服液体制剂的理化和微生物稳定性。
Int J Pharm Compd. 2024 Jul-Aug;28(4):334-343.
4
Development and validation of a paediatric oral formulation of clonidine hydrochloride.开发和验证盐酸可乐定的儿科口服制剂。
Int J Pharm. 2012 Aug 20;433(1-2):119-20. doi: 10.1016/j.ijpharm.2012.04.055. Epub 2012 May 9.
5
Development and Stability Control of Pediatric Oral Tizanidine Hydrochloride Formulations for Hospital Use.儿科盐酸替扎尼定口服液体制剂的开发和稳定性控制。
AAPS PharmSciTech. 2020 Jul 29;21(6):210. doi: 10.1208/s12249-020-01751-8.
6
Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.盐酸可乐定口服液的临时配制稳定性。
Am J Hosp Pharm. 1992 Jan;49(1):122-5.
7
Microbiological quality of pediatric oral liquid formulations.儿科口服液体制剂的微生物质量
Farm Hosp. 2016 Sep 1;40(5):427-35. doi: 10.7399/fh.2016.40.5.10541.
8
Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.卡托普利和依那普利儿科患者临时制剂的物理化学稳定性
Pharm Dev Technol. 2015 May;20(3):271-8. doi: 10.3109/10837450.2013.860552. Epub 2013 Nov 26.
9
Development of a novel physico-chemically and microbiologically stable oral solution of flecainide for pediatrics.开发一种新型物理化学和微生物稳定的氟卡尼口服液,用于儿科。
Pharm Dev Technol. 2018 Dec;23(10):978-985. doi: 10.1080/10837450.2016.1238484. Epub 2016 Oct 26.
10
First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation.儿科口服阿替洛尔制剂的首次开发、优化和稳定性控制。
AAPS PharmSciTech. 2018 May;19(4):1781-1788. doi: 10.1208/s12249-018-0992-5. Epub 2018 Mar 30.

引用本文的文献

1
Study on the Preparation Method of Quality-Assured In-Hospital Drug Formulation for Children-A Multi-Institutional Collaborative Study.儿童院内药品制剂质量保证制备方法的研究——多机构合作研究
Children (Basel). 2023 Jul 10;10(7):1190. doi: 10.3390/children10071190.
2
Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review.儿科心脏病学中口服液体制剂的稳定性:患者安全的先决条件——一篇叙述性综述。
Pharmaceutics. 2023 Apr 21;15(4):1306. doi: 10.3390/pharmaceutics15041306.
3
Pre-formulation and Stability Study of 20-mcg Clonidine Hydrochloride Pediatric Capsules.
20微克盐酸可乐定儿科胶囊的处方前研究与稳定性研究
J Pediatr Pharmacol Ther. 2022;27(7):625-631. doi: 10.5863/1551-6776-27.7.625. Epub 2022 Sep 26.
4
Excipients in the Paediatric Population: A Review.儿科人群中的辅料:综述
Pharmaceutics. 2021 Mar 13;13(3):387. doi: 10.3390/pharmaceutics13030387.